News
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Zomedica Corp. reports record third-quarter revenue growth of 10%, driven by strong performance in Diagnostics and Capital segments. International expansion and positive outlook for 2025 highlighted by CEO Larry Heaton -
-
-
-
-
-
PRESS RELEASE
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
Zomedica sponsors educational programs at Fetch dvm360 Veterinary Conference, showcasing innovative products for animals and veterinarians. Leading experts to present on veterinary challenges and advances -
-
PRESS RELEASE
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
Zomedica partners with Grovet to expand equine product distribution in Europe, introducing TRUFORMA equine platform. New distribution agreement covers 27 countries and includes eACTH and Cortisol assays for equine health